TSP86-DrugMatrix - Toxicogenomic signatures after exposure to lead (ii) acetate in the rat


TSA277-DrugMatrix - Toxicogenomic signatures of Liver after exposure to lead (ii) acetate (600 mg/kg, 3 days) in the rat


TSA278-DrugMatrix - Toxicogenomic signatures of Liver after exposure to lead (ii) acetate (600 mg/kg, 5 days) in the rat


TSA279-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (200 mg/kg, 5 days) in the rat


TSA280-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (600 mg/kg, 3 days) in the rat


TSA281-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (200 mg/kg, .25 days) in the rat


TSA282-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (200 mg/kg, 1 days) in the rat


TSA283-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (200 mg/kg, 3 days) in the rat


TSA284-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (600 mg/kg, 1 days) in the rat


TSA285-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (2 mg/kg, 5 days) in the rat


TSA286-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (600 mg/kg, 5 days) in the rat


TSF277-lead diacetate


1 subfactor(s)
TSF278-lead diacetate


1 subfactor(s)
TSF279-lead diacetate


1 subfactor(s)
TSF280-lead diacetate


1 subfactor(s)
TSF281-lead diacetate


1 subfactor(s)
TSF282-lead diacetate


1 subfactor(s)
TSF283-lead diacetate


1 subfactor(s)
TSF284-lead diacetate


1 subfactor(s)
TSF285-lead diacetate


1 subfactor(s)
TSF286-lead diacetate


1 subfactor(s)
TSS277-DrugMatrix - Toxicogenomic signatures of Liver after exposure to lead (ii) acetate (600 mg/kg, 3 days) in the rat


TSS278-DrugMatrix - Toxicogenomic signatures of Liver after exposure to lead (ii) acetate (600 mg/kg, 5 days) in the rat


TSS279-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (200 mg/kg, 5 days) in the rat


TSS280-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (600 mg/kg, 3 days) in the rat


TSS281-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (200 mg/kg, .25 days) in the rat


TSS282-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (200 mg/kg, 1 days) in the rat


TSS283-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (200 mg/kg, 3 days) in the rat


TSS284-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (600 mg/kg, 1 days) in the rat


TSS285-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (2 mg/kg, 5 days) in the rat


TSS286-DrugMatrix - Toxicogenomic signatures of Kidney after exposure to lead (ii) acetate (600 mg/kg, 5 days) in the rat



TSP86 - DrugMatrix - Toxicogenomic signatures after exposure to lead (ii) acetate in the rat Public

DrugMatrix is the scientific communities' largest molecular toxicology reference database and informatics system. DrugMatrix is populated with the comprehensive results of thousands of highly controlled and standardized toxicological experiments in which rats or primary rat hepatocytes were systematically treated with therapeutic, industrial, and environmental chemicals at both non-toxic and toxic doses.

Interventional Experimental design

No experimental design provided

Results

No results provided